Regencor
PrivateLast Round
Grant
Nov 24, 2021
Total Funding Raised
$8.92M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Regencor operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Grant round in November 2021.
Regencor is a biotechnology company that develops medicines to prevent the progression of heart failure after myocardial infarction by repairing tissue damage and restoring cardiac function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regencor Comparables
Compare Regencor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jaan Biotherapeutics | 84% | |
| Prolifagen | 78% | |
| Medley Therapeutics, Inc. | 76% |
For institutional investors. Book with your work email.
Regencor Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Regencor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Accelerator |
| NIH RADx | Grant |
| California Institute for Regenerative Medicine | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 201% MoM, from 753 to 2.3K.
- Jan 23, 2026
Monthly visitors grew 152% MoM, from 252 to 635.
For institutional investors. Book with your work email.
Regencor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regencor's valuation, stock price, and market status.
Is Regencor a public or private company?
Regencor is a private company.
What is the current stock price of Regencor?
Regencor is a private company, so its shares have no public market price. Caplight tracks Regencor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regencor worth (valuation)?
Valuation information for Regencor is not publicly available.
Can I buy Regencor stock?
Regencor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regencor's last funding round?
Regencor's most recent funding round was Grant on November 24, 2021.
Who are the main investors in Regencor?
Key investors in Regencor include California Institute for Regenerative Medicine.
Will Regencor IPO soon?
No public IPO plans have been announced for Regencor.
How can I track Regencor secondary market activity?
Caplight tracks bids, offers, and trades in Regencor's shares on secondary markets.